A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided, in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine, in admixture, is administered three times per day.

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine in admixture is administered three times per day.

A method for administration of ibuprofen to a subject in need of ibuprofen treatment is provided in which an oral dosage form comprising a therapeutically effective amount of ibuprofen and a therapeutically effective amount of famotidine is administered three times per day.

The present invention relates to a capsule formulation comprising together with an NSAID with anti-inflammatory analgesic and antipyretic activities an H2 receptor antagonist used for preventing or minimizing gastrointestinal side effects caused by NSAID.

The present invention is related to a pharmaceutical formulation which comprises NSAID having antiinflamatory analgesic and antipyretic effect together with an H2 receptor antagonist used for preventing and minimizing the gastrointestinal side effects of NSAID. According to another aspect the present invention relates to the fact that the pharmaceutical formulation comprising NSAID as the first drug substance and H2 receptor antagonist as second active substance is a novel solid oral multilayer ...

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. In some embodiments the ibuprofen is in direct physical contact with the famotidine.